![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/07/shutterstock_2417617489.jpg)
EAN 2024: sublingual apomorphine better tolerated by dopamine agonist users
On 29 June 2024, during an e-presentation session on the topic of movement disorders at the 10th Congress of the European Academy of Neurology (EAN) 2024, Dr Diego Santos García presented posthoc analyses of the Phase III, open-label study on sublingual …